Taken together, these results highlight the spatial specificity with which cell-penetrating peptides cloaked in an MMP-2/9-sensitive scaffold as an ACPP can target conjugated drug payloads to tumors in commonly used pre-clinical xenograft and syngeneic murine cancer models. This evidence concerns the gene ACP3 and cancer.